GlassScriptPhysician profile
David A Nyberg
NPI 1609884022
$2,824.57
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,321 · 2020: $1,404 · 2021: $99.06.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $332.74 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $303.16 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $223.95 | 2019-2020 | |
| Eisai INC. | $220.27 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $204.63 | 2019-2020 | |
| Incyte Corporation | $168.59 | 2019-2020 | |
| Amgen INC. | $122.91 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $118.35 | 2019-2020 | |
| Rigel Pharmaceuticals, INC. | $117.61 | 2020 | |
| Pfizer INC. | $111.04 | 2019-2021 | |
| Janssen Biotech, INC. | $108.85 | 2019-2020 | |
| Clovis Oncology, INC. | $108.56 | 2019-2020 | |
| Foundation Medicine, INC. | $78.42 | 2019-2020 | |
| Lilly USA, LLC | $75.11 | 2019-2020 | |
| Seagen INC. | $68.24 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $58.60 | 2020 | |
| Genentech USA, INC. | $55.32 | 2019-2020 | |
| Exelixis INC. | $52.51 | 2020-2021 | |
| Array Biopharma INC | $44.78 | 2020-2021 | |
| Partner Therapeutics, INC. | $43.79 | 2020 | |
| Astellas Pharma US INC | $35.90 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $34.29 | 2019 | |
| Abbvie INC. | $27.65 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $20.01 | 2019 | |
| Verastem, INC. | $19.86 | 2019 | |
| Glaxosmithkline, LLC. | $17.76 | 2020 | |
| Novocure INC. | $14.56 | 2020 | |
| Jazz Pharmaceuticals INC. | $14.37 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Eagle Pharmaceuticals, INC. | $11.14 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Nyberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.